Advertisement

Search Results for "Baclofen Bij Anorexia"

14:27 EDT 21st May 2013 | BioPortfolio

Original Source: Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder

This study will evaluate the effectiveness of the drug baclofen in reducing binge eating and associated food cravings in people with bulimia nervosa or binge eating disorder.

Matching Channels

Anorexia

Anorexia Nervosa

The main eating disorder, anorexia nervosa, involves extreme weight loss as a result of very strict dieting. The cause is a strong belief held by the patient that they are fat (despite their extreme...

Eating Disorders

Eating disorders include conditions causing under-eating and over-eating. The most common of these are Anorexia and Bulimia. Eating disorders are a serious mental illness that affect 1.6 million peo...

Nutrition

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In cri...

Hepatitis - news, views, blogs and news

Hepatitis (plural hepatitides) is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. The condition can b...

Matching News

IV Baclofen Good for Spasm-Related Pain (CME/CE)

NEW ORLEANS (MedPage Today) -- Intravenous baclofen can effectively combat migraine and muscle spasm pain, researchers found.

Anorexia and Obesity: opposite sides of the reward coin?

We often think of anorexia as a psychiatric problem, a problem of self esteem, a problem of disordered body image. And while it’s probably a lot of these things, treatments based on body image i...

XenoPort: A High Probablity Run-Up Trade

Bybsiflingtrades:When analyzing developmental stage bio-tech companies for potential catalyst-driven trades, I look for a number of specific criteria. In this article I will delve into XenoPort (XNPT)...

Brain Pacemaker May Help Treat Patients With Anorexia

Surgically implanting a pacemaker into the brains of severe anorexia patients may help treat their symptoms. The neurosurgical implant was used safely for the first time in six patients with severe an...

Promising Results For Patients With Chronic, Treatment Resistant Anorexia Nervosa Given Deep Brain Stimulation

In a world first, a team of researchers at the Krembil Neuroscience Centre and the University Health Network have shown that Deep Brain Stimulation (DBS) in patients with chronic, severe and treatment...

DBS helps anorexia patients achieve and maintain improvements in body weight, mood and anxiety

In a world first, a team of researchers at the Krembil Neuroscience Centre and the University Health Network have shown that Deep Brain Stimulation (DBS) in patients with chronic, severe and treatment...

Anorexia Nervosa and the Kidney

How does anorexia nervosa potentially cause kidney problems? This new study takes a close look at the serious renal complications that can arise in this subset of patients. American Journal of Kidne...

Patients with anorexia judge own body size inaccurately, view others' accurately

Patients with anorexia have trouble accurately judging their own body size, but not others', according to research published Aug. 22 in the open access journal PLOS ONE.

Matching PubMed Articles

Use of baclofen for withdrawal in a preterm infant.

Baclofen is a gamma-aminobutyric acid agonist used primarily as a muscle relaxant to treat spasticity in children and adults. Withdrawal of oral baclofen is known to cause a withdrawal syndrome in adu...

Control of esophageal distension-induced secondary peristalsis by the GABA(B) agonist baclofen in humans.

Background  Secondary peristalsis is important for the clearance of retained food bolus or refluxate from the esophagus. The effects of the gamma aminobutyric acid receptor type B (GABA(B) ) agonist...

Acute Intrathecal Baclofen Withdrawal: A Brief Review of Treatment Options.

BACKGROUND: Acute baclofen toxicity and withdrawal can present with a constellation of symptoms making differentiation between these two entities and other potential diagnoses challenging. Baclofen wi...

Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux - a randomised prospective study.

BACKGROUND: Baclofen, a GABA(B) agonist, has been shown to reduce transient lower oesophageal sphincter relaxations (TLESRs), a major cause of gastro-oesophageal reflux disease (GERD). AIM: To examine...

Microwave-assisted synthesis and reversed-phase high-performance liquid chromatographic separation of diastereomers of (R,S)-baclofen using ten chiral derivatizing reagents designed from trichloro-s-triazine.

Four dichloro-s-triazine (DCT) and five monochloro-s-triazine (MCT) chiral derivatizing reagents (CDRs) were synthesized by incorporating amino acid amide moieties as chiral auxiliaries in trichloro-s...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement